MyFinsight
Home
Blog
About
Contact
rnaz: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$1,716,836
Grant receivable
$198,296
Cash
$2,835,916
Deferred offering costs
$455,726
Property and equipment,
net of depreciation
$19,908
Total current assets
$4,751,048
Total assets
$5,226,682
Total liabilities and
stockholders' equity...
$5,226,682
Total stockholders'
equity (deficit)
$1,425,979
Total liabilities
$3,800,703
Accumulated deficit
-$84,419,882
Additional paid-in capital
$85,845,777
Long-term liabilities
$832,875
Total current
liabilities
$2,967,828
Common stock - 0.0001
par value,...
$84
Warrant liability
$832,875
Accounts payable and
accrued expenses
$2,967,828
Back
Back
Balance Sheet
source: myfinsight.com
Transcode Therapeutics, Inc. (RNAZ)
Transcode Therapeutics, Inc. (RNAZ)